Therapeutic Thursday: All In Or Play The Long Game
Aakash Babu
5 min read
members
Pharma and biotech, caught up in minutes
One edition, every weekday. The story behind the headlines, and how to act on them before your next call.
Published by Norstella's News & Insights division, the team behind Pink Sheet, Scrip, In Vivo and the rest of the industry's most-read mastheads.
Latest issues
Watchdog Wednesday: The User Fee Deal That Skipped Dessert
Nielsen Hobbs
6 min read
members
Trial Tuesday: Idiopathic Pulmonary Fibrosis Waits On Its Groundhog Day
Manas Mishra
4 min read
members
Milestone Monday: Count the Events, Not the Paperwork
Capsul Desk
5 min read
members
The Long View: Two Ways To Do A Deal
Mary Jo Laffler
6 min read
members
Therapeutic Thursday: A New Neighbourhood For mRNA
Aakash Babu
3 min read
members
Watchdog Wednesday: The Evolution Of EMA’s Real-World Evidence Policy
Nielsen Hobbs
6 min read
members
Trial Tuesday: The Slow Drift Out Of US Trials
The US still has the biggest market and the deepest regulatory expertise but early-stage sponsors are increasingly starting somewhere else.
Manas Mishra
4 min read
members
Milestone Monday: In This IPO Market, $81m Is The Small One
Capsul Desk
4 min read
members
The Long View: Sanofi Rebuilds Its Workforce Around AI, Just As It Gets Pickier About What Advances
The discovery engine now runs twice as fast. A new chief executive is culling late-stage assets and raising the Phase II bar, so the bet rides on whether faster also means better.
Capsul Desk
6 min read
members
Therapeutic Thursday: The Good, The Bad And The Ugly
Aakash Babu
5 min read
members
Watchdog Wednesday: How To Avoid Starring In A Harrison Ford Movie
Nielsen Hobbs
8 min read
members